2026年,AI制药开门红!仅仅过了半个月,AI药物研发合作密集发布。据统计,15天内跨国药企AI制药相关合作已经超过9起,总额超60亿美元。数据来源:智药局合作方式也多种多样,不仅有传统项目制,还有模型订阅、平台共建,以及收购项目。也就是说,大型药企正将AI,尤其是生物医药大模型,系统性地纳入核心研发流程。AI不再只是小规模试点,而是作为提升效率和突破研发瓶颈的关键手段。01从买管线,到共建平台...
Source Link2026年,AI制药开门红!仅仅过了半个月,AI药物研发合作密集发布。据统计,15天内跨国药企AI制药相关合作已经超过9起,总额超60亿美元。数据来源:智药局合作方式也多种多样,不仅有传统项目制,还有模型订阅、平台共建,以及收购项目。也就是说,大型药企正将AI,尤其是生物医药大模型,系统性地纳入核心研发流程。AI不再只是小规模试点,而是作为提升效率和突破研发瓶颈的关键手段。01从买管线,到共建平台...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.